A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
Status:
Recruiting
Trial end date:
2022-05-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy of once weekly
dulaglutide when added to insulin glargine, with metformin and/or acarbose in Chinese
participants with type 2 diabetes mellitus.